MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-04-2025
Nevro Corp. Operating Income 2011-2026 | NVRO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -126 M | -99.3 M | 6.16 M | -111 M | -62.9 M | -96.5 M | -41.7 M | -29.6 M | -23.1 M | -62.4 M | -28.3 M | -25.2 M | -19.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.16 M | -126 M | -55.3 M |
Quarterly Operating Income Nevro Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.9 M | -25.1 M | -35.8 M | - | -25.6 M | -25.6 M | -36.3 M | - | 82.1 M | -23.8 M | -32.8 M | - | -46.4 M | -15.8 M | -22.5 M | -875 K | -3.55 M | -35.4 M | -23.1 M | -11.7 M | -16 M | -26.6 M | -42.3 M | -8.6 M | -9.24 M | -8.2 M | -15.7 M | -2.17 M | -4.42 M | -9.94 M | -13.1 M | -6.27 M | -1.87 M | -5.92 M | -9.02 M | -13.1 M | -17.7 M | -19.2 M | -12.3 M | -7.11 M | -6.5 M | -7.46 M | -7.24 M | -6.54 M | -5.36 M | -6.19 M | -7.06 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 82.1 M | -46.4 M | -13.4 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.86 | -1.72 % | $ 1.74 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 25.1 | -0.59 % | $ 212 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.36 | 1.46 % | $ 126 M |  France |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 10.57 | 2.2 % | $ 299 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.63 | -1.29 % | $ 39.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.0 | 1.01 % | $ 1.22 M | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.09 | 5.9 % | $ 18.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 14.76 | 0.82 % | $ 346 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.28 | -13.01 % | $ 906 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 58.53 | -0.66 % | $ 3.19 B |  Britain |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 88.23 | 0.49 % | $ 11.9 B | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.25 | 0.39 % | $ 367 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 169.75 | 6.08 % | $ 11.9 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 38.59 | 7.31 % | $ 1.2 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 53.41 | - | $ 1.57 B | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.0 | 0.5 % | $ 5.55 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 83.01 | -0.79 % | $ 2.88 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 80.96 | -0.32 % | $ 47.3 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 314.5 | -0.2 % | $ 120 B | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 22.53 | 0.13 % | $ 515 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.84 | -1.79 % | $ 39.4 M | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 98.83 | 0.26 % | $ 3.36 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 18.77 | 3.33 % | $ 1.28 B | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.38 | -0.19 % | $ 64.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.25 | 4.17 % | $ 50.9 M | USA |